...
首页> 外文期刊>Frontiers in Veterinary Science >The History of In Vivo Tuberculin Testing in Bovines: Tuberculosis, a “One Health” Issue
【24h】

The History of In Vivo Tuberculin Testing in Bovines: Tuberculosis, a “One Health” Issue

机译:牛体内结核菌素检测的历史:结核病,“一个健康”的问题

获取原文

摘要

Tuberculosis (TB) is more than 3 million years old thriving in multiple species. Ancestral Mycobacterium tuberculosis gave rise to multiple strains including Mycobacterium bovis (M. bovis) now distributed worldwide with zoonotic transmission happening in both directions between animals and humans. M. bovis in milk caused problems with a significant number of deaths in children under 5 years of age due largely to extra-pulmonary TB. This risk was effectively mitigated with widespread milk pasteurization during the 20thC and fewer young children were lost to TB. Koch developed tuberculin in 1890 and recognising the possibility of using tuberculin to detect infected animals the first tests were quickly developed. Bovine TB (bTB) control/eradication programmes followed in the late 19thC/early 20thC. Many scientists collaborated and contributed to the development of tuberculin tests, to refining and optimising the production and standardisation of tuberculin and to determining test sensitivity and specificity using various methodologies and injection sites. The WHO, OIE and EU have set legal standards for tuberculin production, potency assay performance and intradermal tests for bovines. Now, those using tuberculin tests for bTB control/eradication programmes rarely, see TB as a disease. Notwithstanding the launch of the first-ever roadmap to combat zoonotic TB, many wonder if bTB is actually a problem?; is there a better way of dealing with bTB; might alternative skin test sites make the test ‘better’ and easier to perform; are all tuberculins used for testing equally good?; why haven’t alternative ‘better’ tests been developed? This review was prompted by these types of questions. This paper attempts to succinctly summarise the data from the literature from the late 19thC to date to show why TB, and zoonotic TB specifically, was and still is important as a ‘One Health’ concern, and that the necessity to reduce the burden of zoonotic TB, to save lives and secure livelihoods is far too important to await the possible future development of novel diagnostic assays for livestock before renewing efforts to eliminate it. Consequently, it is highly probable that the tuberculin skin test will remain the screening test of choice for farmed livestock for the considerable future.
机译:结核病(TB)已有300万年历史,已经在多种物种中繁衍。祖先结核分枝杆菌产生了多种菌株,包括牛分枝杆菌(牛分枝杆菌),现已在世界范围内传播,在动物和人之间双向发生人畜共患病传播。牛奶中的牛分枝杆菌导致5岁以下儿童大量死亡的问题,主要是由于肺外结核。通过在20世纪C期间进行广泛的牛奶巴氏消毒,可以有效地缓解这种风险,并且减少了因结核病流失的幼儿。 Koch于1890年开发了结核菌素,并认识到使用结核菌素检测受感染动物的可能性,很快就开展了第一个试验。 19世纪末/ 20世纪初实施了牛结核病(bTB)控制/根除计划。许多科学家共同合作,为结核菌素检测的开发,精炼和优化结核菌素的生产和标准化以及使用各种方法和注射部位确定检测灵敏度和特异性做出了贡献。世卫组织,世界动物卫生组织和欧盟已为牛的结核菌素生产,效能测定性能和皮内试验制定了法律标准。现在,那些将结核菌素检测用于bTB控制/根除计划的人很少,将TB视为疾病。尽管有史以来首个抗击人畜共患结核病的路线图发布,但许多人仍在想bTB是否真的存在问题?有没有更好的应对bTB的方法;替代性皮肤测试网站可能会使测试“更好”并且更容易执行;用于测试的所有结核菌素是否都一样好?为什么没有开发替代性的“更好”的测试?这些类型的问题提示了该评论。本文试图对19世纪末以来的文献数据进行简要总结,以说明为什么结核病,特别是人畜共患结核病,作为“一个健康”问题,至今仍很重要,以及减轻人畜共患疾病负担的必要性对于挽救生命和确保生计的结核病来说,太重要了,以至于在为消灭牲畜而进行新的努力之前,等待着将来可能出现的新型牲畜诊断分析方法的发展。因此,很可能结核菌素皮肤试验将在相当长的将来仍然是养殖牲畜的首选筛选试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号